Access Pharmaceuticals |
|
||
| Access' lead anticancer program is ProLindac™ applies the principals of nanoparticulate prodrugs to enhance the delivery of a platinum drug to tumors. | |||
| Address: | 2600 Stemmons Freeway, Suite 176 | ||
| City: | Dallas | ||
| State/Province: | Texas | ||
| Postcode: | 75207-2107 | ||
| Country: | USA | ||
